GrayBug Competitors and Similar CompaniesClear all
Harbour Antibodies's competitors and similar companies include PellePharm and PDC Line Pharma.
 Harbour Antibodies Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies. |  PDC Line Pharma PDC Line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. | ||
Founding Date | Founding Date 2006 | Founding Date 2012 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Newton, US HQ | Locations San Francisco, US HQ | Locations La Tronche, FR HQ Liège, BE |
Employees | Employees 1 | Employees 5 | Employees 375% decrease |
Funding | |||
Latest funding round | Latest funding round $ 3.2m (almost 13 years ago) | Latest funding round $ 70m (over 7 years ago) | Latest funding round $ 22.2m (over 6 years ago) |
Total funding raised | Total funding raised $ 3.2m | Total funding raised $ 81.4m | Total funding raised $ 26.5m |
For sources of this data, please see the company profile
View Company Profiles
PellePharm
HQ
San Francisco, US
Employees
5
PellePharm, Inc. operates in the biotechnology industry.
View companyPDC Line Pharma
HQ
La Tronche, FR
Employees
37↓ 5% decrease
PDC Line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens.
View company